INATHERYS Information

INATHERYS is a clinical-stage biotech advancing precision drug delivery, turning cancer’s energy dependency against itself. Our lead asset, an ADC targeting CD71/TfR1, is designed to address critical needs in treating proliferative cancers.

Website	https://www.inatherys.com
Revenue	$4 million
Employees	3 (1 on RocketReach)
Address	4 Rue Pierre Fontaine, Evry Cedex, Wallis and Futuna 91058, FR
Technologies	HTML , Google Analytics , Google Tag Manager +3 more (view full list)
Industry	Biotechnology, Business Services General, Business Services, Science and Engineering, Health Care, Medical
Keywords	Innovative Cancer Treatments, Precision Medicine, Cancer Treatment, Adc Technology, Clinical Stage Biotech, Biotechnology, Drug Delivery Systems, Targeted Therapy, Cancer Research, Oncology, Pharmaceutical Research, Therapeutic Antibodies, Biopharma, Drug Development, Cancer Therapies
Competitors	Isobar Mexico, Aeris Communications, Cropin, Synthesis Capital Markets, Foresight Solutions Group, Sertica, Green Frame, Neptune Solutions, OSMA Cosmetics & Laboratories AG, OCEANIX +5 more (view full list)
SIC	SIC Code 873 Companies, SIC Code 87 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies